Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA) Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
Circulation 2021 May 16;[EPub Ahead of Print], SL Heck, A Mecinaj, AH Ree, P Hoffmann, JE Schulz-Menger, MW Fagerland, B Gravdehaug, H Røsjø, K Steine, J Geisler, G Gulati, T OmlandFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.